FormWeb • gadobenate dimeglumine

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

gadobenate dimeglumine

gadobenate dimeglumine

Restricted Multihance --> Multihance is restricted to selected cardiac imaging studies and follow-up study where Multihance was the imaging agent originally used.

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Multihance	SOLUTION, INTRAVENOUS	529 mg/mL

Comments:

Multihance is restricted to selected cardiac imaging studies and follow-up study is desired where Multihance was the imaging agent originally used. Prohance is the main formulary agent for radiology group.

Reviewed: April 25, 2006, and July 27, 2010, and 28 Nov 2017

Last updated: Dec. 6, 2017

Black Box Warning: Nephrogenic Systemic Fibrosis

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.